<PAGE>

                UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                   FORM 10-QSB

              [X] Quarterly Report Pursuant to Section 13 or 15(d)
                     of the Securities Exchange Act of 1934
                For the quarterly period ended September 30, 2002

                                       or
            [ ] Transition Report Pursuant to Section 13 or 15 (d) of
                       the Securities Exchange Act of 1934

                           COMMISSION FILE NO. 0-26809

                               ARMAGH GROUP, INC.
                               ------------------
             (Exact name of registrant as specified in its charter)

              DELAWARE                             91-1962104
     ------------------------        ---------------------------------------
     (State of incorporation)        (I.R.S. Employer Identification Number)


                             412 - 111 Peter Street
                                Toronto, Ontario
                                     M5V 2H1
                                     -------
               (address of principal executive offices) (Zip Code)


                                 (416) 591-8611
                                 --------------
              (Registrant's telephone number, including area code)

                      SHARPS ELIMINATION TECHNOLOGIES INC.
                         Suite 310, The Pemberton Bldg.
                            744 West Hastings Street
                             Vancouver, B.C. V6C 1A5
                             -----------------------
           Former name and former address if changed since last report

Indicate by check mark whether the registrant: (1) has filed all reports
required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of
1934 during the proceeding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.

                                 YES [X] NO [ ]


As of November 12, 2002, the Company had 8,848,119 issued and outstanding shares
of common stock.

<PAGE>

                         PART I -- FINANCIAL INFORMATION

                          ITEM 1. FINANCIAL STATEMENTS

                               ARMAGH GROUP, INC.
                (FORMERLY SHARPS ELIMINATION TECHNOLOGIES, INC.)
                      CONSOLIDATED CONDENSED BALANCE SHEETS

                                                     September 30,
                                                        2002         December 31
                                                     (Unaudited)        2001
--------------------------------------------------------------------------------

ASSETS
TOTAL ASSETS                                         $        --    $       271
================================================================================

LIABILITIES AND STOCKHOLDERS' DEFICIT
CURRENT LIABILITIES
   Accounts payable                                  $     7,095    $   195,324
   Due to related parties                                                93,888
   Loan payable                                          122,854        145,209
   Convertible note payable                                             146,687
--------------------------------------------------------------------------------
TOTAL CURRENT LIABILITIES                                129,949        581,108

TOTAL LIABILITIES                                        129,949        501,108
--------------------------------------------------------------------------------

STOCKHOLDERS' DEFICIT
   Common stock, $0.001 par value; 50,000,000
    shares authorized, 8,848,119 issued
    and outstanding                                        8,848         18,213
   Additional paid-in capital                          5,660,435      4,525,087
   Accumulated deficit                                (5,799,232)    (5,124,137)
--------------------------------------------------------------------------------

TOTAL STOCKHOLDERS' DEFICIT                             (129,949)      (580,837)
--------------------------------------------------------------------------------

TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT          $        --    $       271
================================================================================


     See accompanying notes to consolidated condensed financial statements.

                                       1
<PAGE>

<TABLE>
                                    ARMAGH GROUP, INC.
                     (FORMERLY SHARPS ELIMINATION TECHNOLOGIES, INC.)
                     CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
              FOR THE PERIODS ENDED SEPTEMBER 30, 2002 AND SEPTEMBER 30, 2001
                                        (UNAUDITED)

<CAPTION>
                                         Three Months Ended              Nine Months Ended
                                             September                        September
                                   -------------------------------------------------------------
                                        2002          2001              2002           2001
------------------------------------------------------------------------------------------------

<S>                                <C>             <C>             <C>             <C>
OPERATING EXPENSES
 General and administrative        $     10,854    $         --    $     10,854    $         --

LOSS FROM CONTINUING OPERATIONS         (10,854)             --         (10,854)             --
------------------------------------------------------------------------------------------------
DISCONTINUED OPERATIONS
 Loss on discontinued operations       (171,713)       (898,455)       (664,241)     (3,264,669)
------------------------------------------------------------------------------------------------

NET INCOME (LOSS)                  $   (182,567)   $   (898,455)   $   (675,095)   $ (3,264,669)
================================================================================================

  NET INCOME (LOSS) PER SHARE -
        BASIC AND DILUTED          $      (0.02)   $      (0.05)   $      (0.08)   $      (0.30)
================================================================================================

WEIGHTED AVERAGE NUMBER
  OF SHARES OF COMMON
  STOCK OUTSTANDING                   8,848,119      16,652,676       9,238,154      10,910,717
================================================================================================

          See accompanying notes to consolidated condensed financial statements.

                                            2
</TABLE>
<PAGE>

<TABLE>
                                         ARMAGH GROUP, INC.
                          (FORMERLY SHARPS ELIMINATION TECHNOLOGIES, INC.)
                            CONSOLIDATED CONDENSED STATEMENT OF CASH FLOW
                               FOR THE PERIOD ENDED SEPTEMBER 30, 2002
                                            (Unaudited )

<CAPTION>
                                                 Three Months Ended September  Nine Months Ended September
                                                       2002         2001            2002          2001
----------------------------------------------------------------------------------------------------------

<S>                                                 <C>          <C>            <C>           <C>
CASH FLOWS FROM OPERATING ACTIVITIES
   Net income (loss)                                $(182,567)   $ (898,455)    $ (675,095)   $(3,264,669)
   Adjustments to reconcile net loss to net
    cash provided by (used in) operating
    activities:
     Loss on discontinued operations                  171,713       898,455        664,241      3,264,669
     Change in assets and liabilities                  10,854            --         11,125             --
----------------------------------------------------------------------------------------------------------

NET CASH PROVIDED BY (USED IN) OPERATING
ACTIVITIES                                                 --            --           (271)            --
----------------------------------------------------------------------------------------------------------

NET INCREASE/DECREASE IN CASH AND CASH
EQUIVALENTS                                                --            --             --             --
----------------------------------------------------------------------------------------------------------

CASH AND CASH EQUIVALENTS, beginning of period             --            --            271             --
==========================================================================================================

CASH AND CASH EQUIVALENTS, end of period            $      --    $       --     $       --    $        --


Cash paid during the period for interest            $      --    $       --     $       --    $     4,232

NON-CASH INVESTING AND FINANCING ACTIVITIES:
     Purchase of financed furniture and
        equipment                                   $      --    $       --     $       --    $   140,617
     Conversion of notes payable to common stock    $      --    $  167,500     $  149,385    $   167,500
     Conversion of loans payable to common stock    $      --    $       --     $  189,198    $        --
     Conversion of accounts payable to common
        stock                                       $      --    $       --     $  229,722    $        --
     Issuance of common stock for services          $      --    $       --     $  457,678    $        --
     Issuance of common stock pursuant to reverse
        acquisition                                 $      --    $ (435,065)    $       --    $  (435,065)
----------------------------------------------------------------------------------------------------------

               See accompanying notes to consolidated condensed financial statements.

                                                 3
</TABLE>
<PAGE>


                                ARMAGH GROUP INC.
                 (FORMERLY SHARPS ELIMINATION TECHNOLOGIES INC.)

              NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
                                   (Unaudited)

NOTE 1.  BUSINESS DESCRIPTION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Except where the context indicates otherwise, references in this Quarterly
Report on Form 10-Q to the "Company" refers to the registrant, Armagh Group
Inc., a Delaware corporation.

The Company was incorporated in the State of Florida on August 17, 1984, under
the name of AIDA Industries, Inc. and on December 19, 2000, redomiciled to the
state of Delaware. From its inception until July 20, 1998, there was no activity
within the Company. On July 20, 1998, the Company amended its Articles of
Incorporation to provide for a thousand to one (1,000:1) stock split and was
quoted on the OTC Bulletin Board. The Company began operations in January of
1999, and on March 24, 1999, the Company changed its name from AIDA Industries,
Inc. to Shopping Sherlock, Inc. On May 5, 2001, the Company changed its name
from Shopping Sherlock, Inc. to ASPi Europe, Inc. On May 3, 2002 changed its
name to Sharps Elimination Technologies Inc. On September 9, 2002, the Company
changed its name to Armagh Group Inc.

On June 11, 2001 and amended on June 29, 2001, the Company executed an
Amalgamation and Re-Organization Agreement (the "Re-Organization Agreement") to
acquire all of the issued and outstanding equity securities of GrowthExperts
Group Inc. ("GrowthExperts") in exchange for up to 10,500,000 shares of common
stock of the Company and the assumption of all options to purchase equity
securities of GrowthExperts. GrowthExperts is an Alberta corporation that
provided outsourced customer relationship management services.

The acquisition of GrowthExperts was treated as a reverse acquisition whereby
the Company was acquired by GrowthExperts, with the unaudited balance sheets
being combined using each company's historical cost basis. The results of
operations include that of both companies from the date of closing the
acquisition, July 9, 2001, forward. The financial statements for the period
prior to the date of acquisition are those of GrowthExperts. The equity section
of the balance sheet and the net loss per share of the Company are retroactively
restated to reflect the effect of the exchange ratio established in the asset
purchase agreement.

On December 5, 2001, due to GrowthExperts' lack of working capital and failure
to meet current minimum obligations, GrowthExperts filed an assignment into
bankruptcy under Canada's Bankruptcy and Insolvency Act. A trustee was named in
the bankruptcy proceedings and took immediate possession of GrowthExperts'
assets and closed all of GrowthExperts' offices.

On January 22, 2002, the Company entered into the Stock Redemption and
Settlement Agreement (the "Redemption Agreement") with Scott Dow and F. Thomas
Winters III under which the parties agreed to a mutual release of liability in
consideration for, among other things, the redemption of 2,944,611 Exchangeable
Shares that Mr. Dow and Mr. Winters owned or had control over, stock options for
300,000 shares of the Company's common stock which Mr. Winters had the right to
purchase and the release of Mr. Dow and Mr. Winters from their personal
guarantees on a $150,000 promissory note issued by the Company to GrowthExperts
on May 1, 2001.

                                       4
<PAGE>

At a special meeting of GrowthExperts' Exchangeable Shareholders held on January
22, 2002, the Exchangeable Shareholders voted in favor of amending certain
exchange and voting rights attached to their Exchangeable Shares such that the
10,500,000 Exchangeable Shares issued were no longer exchangeable into common
shares of the Company and carried no voting rights.

On February 11, 2002, the Company announced that it entered into a letter of
intent to acquire all of the issued and outstanding equity securities of Sharps
Elimination Technologies Inc. ("SETI") a Delaware corporation based in Oxford,
Mississippi that is focused on the prevention of needlestick injuries through
the use of its exclusive license to develop, manufacture and sell the
Needle-Ease(TM) device. Under the terms of the letter of intent, the Company
intended to acquire all of SETI's outstanding securities in exchange for
15,800,000 shares of common stock of the Company.

On March 22, 2002, Kelly Fielder was appointed the Chief Executive Officer and
sole Director of the Company. Mr. Fielder is also the Chief Executive Officer
and Director of SETI.

On March 25, 2002, the Company acquired all of the issued and outstanding equity
securities of SETI in exchange for 15,800,000 shares of the Company's common
stock.

In April 2002 the Company changed its name from "ASPi Europe Inc." to "Sharps
Elimination Technologies Inc."

In March 2002, the Company acquired SETI in exchange for 15,800,000 shares of
common stock. A the time of the acquisition, SETI was planning to sell devices,
which would safely incinerate used medical needles. The Company acquired SETI as
a result of SETI's desire to have a public market for its stock. SETI believed
that the existence of a public trading market for its common stock would make it
easier to raise the capital needed to finance SETI's operations. However,
potential investors have expressed concern due to the volatility in the price of
the Company's stock. Accordingly, management is of the opinion that:

1.       Raising funds with the Company's present capital structure would be
         both difficult and costly and that the holdings of the Company's
         present shareholders would likely be significantly diluted as a result
         of the sale of the additional shares which would be required to finance
         the development of the Company's medical needle disposal business.

2.       The best interests of the Company's shareholders would be served by
         rescinding the agreement relating to the acquisition of SETI and then
         acquiring another business which would not need the substantial capital
         required by the Company's medical needle disposal business.

Accordingly, in August 2002 the Company and the former shareholders of SETI
agreed to rescind the acquisition of SETI. The agreement to rescind the
acquisition of SETI was approved by shareholders owning a majority of the
Company's outstanding shares. On the effective date, all of the issued and
outstanding shares of SETI were returned to the former SETI shareholders and the
15,800,000 shares issued to the former SETI shareholders will be returned to
treasury and cancelled.

The Agreement between the Company and the former shareholders also provided for
the following:

The Company paid to SETI $62,000 to reimburse SETI for its expenses incurred in
connection with the Company's acquisition of SETI and for other expenses
following the date of the acquisition.

SETI will be responsible for approximately $500,000 of the combined liabilities
of the Company and SETI. The Company will be responsible for remaining
liabilities of approximately $14,000.

                                       5
<PAGE>

SETI will assume all material contractual obligations incurred by the Company
subsequent to the acquisition of SETI in March 2002, except for those relating
to those liabilities for which the Company will remain liable. SETI will remain
responsible for its own contractual obligations.

On the effective date of the rescission, Adrian Towning and Darren Breitkreuz
were appointed as directors of the Company. Following this appointment, Kelly
Fielder resigned as an officer and director of the Company.

Following the rescission of SETI acquisition, the Company will no longer have
any revenue generating assets or operations but will be free to seek new
acquisition or business opportunities.

ACCOUNTING ESTIMATES - The Company's financial statements are prepared in
conformity with accounting principles generally accepted in the United States of
America which requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of contingent
assets and liabilities at the date of the financial statements, and the reported
amounts of revenue and expenses during the reporting period. Actual results
could differ from the estimates.

CASH AND CASH EQUIVALENTS - The Company considers all highly liquid investments
purchased with an original maturity of three months or less to be cash
equivalents. Cash and cash equivalents consist primarily of deposits at
federally insured financial institutions.

LONG-LIVED ASSETS - In accordance with Statement of Financial Accounting
Standards ("SFAS") No. 121, "Accounting for the Impairment of Long-Lived Assets
and for Long-Lived Assets to be Disposed Of," the Company records impairment
losses on long-lived assets used in operations whenever events or circumstances
indicate that the carrying amount of an asset may not be recoverable based on
undiscounted cash flows. An impairment is recognized to the extent that the sum
of undiscounted estimated future cash flows expected to result from use of the
assets is less than the carrying value.

FAIR VALUE OF FINANCIAL INSTRUMENTS - The Company's financial instruments
include cash, accounts receivable and notes payable, which due to the nature and
duration of the financial instruments, approximates their fair value.

STOCK-BASED COMPENSATION - SFAS No. 123, "Accounting for Stock-based
Compensation," establishes a fair value method of accounting for stock-based
compensation plans and for transactions in which a company acquires goods or
services from non-employees in exchange for equity instruments. SFAS 123 also
gives the option to account for stock-based employee compensation in accordance
with Accounting Principles Board Opinion ("APB") No. 25, "Accounting for Stock
Issued to Employees," or SFAS 123. The Company elected to follow APB 25 which
measures compensation cost for employee stock options as the excess, if any, of
the fair market price of the Company's stock at the measurement date over the
amount an employee must pay to acquire the Company's stock by exercise of the
stock options granted.

FOREIGN CURRENCY - Exchange gains and losses from holding foreign currencies and
having liabilities in foreign currencies are included in the consolidated
condensed statements of operations.

RECENT ACCOUNTING PRONOUNCEMENTS - In June 2001, the FASB approved for issuance
SFAS 141, Business Combinations. This standard eliminates the pooling method of
accounting for business combinations initiated after June 30, 2001. In addition,
SFAS 141 addresses the accounting for intangible assets and goodwill acquired in
a business combination. This portion of SFAS 141 is effective for business
combinations completed after June 30, 2001. The Company does not expect SFAS 141
to have a material effect on the Company's financial position or results of
operations.

                                       6
<PAGE>

In June 2001, the FASB approved for issuance SFAS 142, Goodwill and Intangible
Assets, which revises the accounting for purchased goodwill and intangible
assets. Under SFAS 142, goodwill and intangible assets with indefinite lives
will no longer be amortized, but will be tested for impairment annually and also
in the event of an impairment indicator. SFAS 142 is effective for the fiscal
years beginning after December 15, 2001, with early adoption permitted for
companies with fiscal years beginning after March 15, 2001 if their first
quarter financial statements have not been previously issued. The Company does
not expect SFAS 142 to have a material effect on the Company's financial
position or results of operations.

In June 2001, the FASB issued SFAS 143, Accounting for Asset Retirement
Obligations, which is effective for fiscal years beginning after June 15, 2002.
SFAS 143 addresses the financial accounting and reporting obligations and
retirement costs related to the retirement of tangible long-lived assets. The
Company does not expect that the adoption of SFAS 143 will have a significant
impact on its financial position and results of operations.

In August 2001, the FASB issued SFAS 144, Accounting for the Impairment of
Disposal of Long-Lived Assets, which is effective for the fiscal years beginning
after December 15, 2001. SFAS 144 supersedes SFAS 121, Accounting for the
Impairment of Long-Lived Assets and for Long-Lived Assets to be Disposed Of, and
the accounting and reporting provisions relating to the disposal of a segment of
a business of Accounting Principles Board Opinion No. 30. The Company does not
expect that the adoption of SFAS 144 will have a significant impact on its
financial position and results of operations.

NOTE 2.  BASIS OF PRESENTATION

The accompanying consolidated condensed financial statements of the Company are
unaudited and include, in the opinion of management, all normal recurring
adjustments necessary to present fairly the consolidated condensed balance sheet
as of September 30, 2002, and the related statements of operations,
stockholders' deficit and cash flows for the periods presented. Certain
information and footnote disclosures normally included in financial statements
prepared in accordance with accounting principles generally accepted in the
United States of America have been condensed or omitted pursuant to the rules
and regulations of the Securities and Exchange Commission (the "Commission").
These consolidated condensed financial statements should be read in conjunction
with the Company's fiscal 2001 audited consolidated financial statements and the
related notes thereto included in the Company's Form 10-K filed with the
Commission on April 19, 2002.

Since Armagh ("parent") is the surviving legal entity after the disposition of
SETI the historical accounting presented herein includes the balances of the
parent only.

NOTE 3.  GOING CONCERN

The Company has never generated profits, and there is no assurance that, in the
future, the Company will be profitable on a quarterly or annual basis. The
Company expects to continue to incur operating losses until significant funding
can be obtained.

The Company believes that it has access to additional capital to sustain
operations through December 2002. The Company cannot assure that funds raised in
the future will be sufficient to finance the complete cost of its operations.
The Company will require additional funds before the Company can achieve
positive cash flow from operations. The Company is actively in the process of
raising additional capital. The Company cannot assure that additional financing
or additional funds will be available when the Company needs them or, if
available, on terms acceptable to the Company. If adequate funds are not
available, the Company may not be able to continue. Any additional stock or

                                       7
<PAGE>

convertible debt financing which the Company obtains, if any, could result in
substantial dilution to stockholders. The Company currently has no commitments
for any credit facilities such as revolving credit agreements or lines of credit
that could provide additional working capital and substantial doubt exists
regarding the Company's ability to continue as a going concern.

NOTE 4.  DISCONTINUED OPERATIONS

On December 5, 2001, the Company's wholly-owned subsidiary, GrowthExperts, filed
an assignment into bankruptcy, which effectively transferred control of all the
GrowthExperts' assets and obligations to the bankruptcy trustee and ceased all
its operating activities. As a result, the Company has reclassified its prior
year financial statements to present the operating results as a discontinued
operation.

During the period September 30, 2002 Armagh, disposed of its only operating
subsidiary, SETI, in exchange of shares. The shareholders of SETI exchanged
15,800,000 shares of Armagh for all the outstanding shares of SETI. The exchange
was treated as a recapitalization transaction reversing the effects of the March
25, 2002 acquisition of SETI.

NOTE 5.  NET LOSS PER SHARE

Basic loss per share is computed by dividing net loss by the weighted average
number of common stock outstanding. Per share information for all prior periods
have been retroactively restated to reflect the effect of the exchange ratio
established in the Re-Organization Agreement with GrowthExperts. As of September
30, 2002, the Company had outstanding options to purchase 200,000 shares of
common stock and outstanding warrants to purchase 575,500 shares of common stock
which were not included in the calculation of loss per share as their effect was
anti-dilutive.

NOTE 6.  CONVERTIBLE NOTE PAYABLE

On May 17, 2000, the Company issued $125,000 of convertible subordinated debt to
a third party. The note had a maturity date of August 31, 2001 with interest
accruing at the rate of 10% per annum through July 31, 2001 and 12.5%
thereafter. The note is convertible into common stock at a price equal to 80% of
the trading price of the common stock on the date such advance is converted. On
March 4, 2002, the note and related accrued interest was converted into 149,385
shares of the Company's common stock at an agreed-upon price of $1.00 per share.
On the conversion date, 80% of the trading price of the common stock was $1.10.

NOTE 7.  LOANS PAYABLE

On January 22, 2001, the Company issued a $50,000 promissory note to an
individual. The note had a maturity date of May 18, 2001 with interest accruing
at the rate of 10% per annum. On August 6, 2001, the note was amended such that
the principal and accrued interest was due October 15, 2001 and the interest
would accrue at 12.5% per annum effective July 31, 2001. On May 1, 2002, the
note and related accrued interest was converted into 57,140 shares of the
Company's common stock.

On August 15, 2001, the Company issued a $50,000 promissory note to a third
party. The note had a maturity date of November 30, 2001 with interest accruing
at the rate of 12% per annum. On March 13, 2002, the note and related accrued
interest was converted into 53,452 shares of the Company's common stock.

On November 2, 2001, the Company issued a $37,000 promissory note to a third
party. The note had a maturity date of November 30, 2001 with interest accruing

                                       8
<PAGE>

at the rate of 12% per annum. On March 15, 2002, the note and related accrued
interest was converted into 38,606 shares of the Company's common stock.

On March 21, 2002, the Company received a short term loan in the amount of
$40,000. On April 9, 2002, the loan was converted into 40,000 shares of the
Company's common stock.

NOTE 8.  STOCKHOLDERS' DEFICIT

On March 25, 2002, the Company sold 100,000 shares of common stock for an
aggregate of $100,000 to an investor. In connection with this sale, the Company
issued one-year warrants to purchase 50,000 shares of common stock at an
exercise price of $1.50 per share and three-year warrants to purchase 50,000
shares of common stock at an exercise price of $2.00 per share. In connection
with this sale, the Company granted the investor certain registration rights
with respect to 100,000 shares of the common stock and the underlying shares to
be issued upon the exercise of the above described warrants.

During the nine months ended September 30, 2002, the Company issued 229,722
shares of common stock to creditors of the Company to extinguish approximately
$229,722 in accounts payables. Of these amounts, approximately $95,200 was due
to related parties.

Also, during the nine months ended September 30, 2002, the Company issued
466,667 of common stock to certain consultants of the Company for services
rendered. The transactions totaled in the aggregate $466,667.

                                       9
<PAGE>

                                 PART I - ITEM 2
                     MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                    FINANCIAL CONDITION AND PLAN OF OPERATION

         The Company was incorporated in 1984. Between 1984 and August 2002 the
Company was involved in several businesses, all of which have been discontinued.

         In June 2001 the Company acquired all of the issued and outstanding
equity securities of GrowthExperts Group Inc. in exchange for 9,750,000
Exchangeable Shares. Each Exchangeable Shares was exchangeable at any time, at
the holders option, for one share of the Company's common stock. On October 7,
2001, the former GrowthExperts shareholders were issued an additional 750,000
Exchangeable Shares due to the Company's failure to meet certain obligations to
GrowthExperts.

         GrowthExperts was formed to provide outsourced sales and customer
relationship management services. On December 5, 2001, GrowthExperts filed
bankruptcy under Canada's Bankruptcy and Insolvency Act due to lack of working
capital. At a special meeting of GrowthExperts' Exchangeable Shareholders held
on January 22, 2002, the Exchangeable Shareholders voted to amend the rights
attached to the Exchangeable Shares such that the 10,500,000 Exchangeable Shares
would no longer be exchangeable into common shares of the Company.

         On March 26, 2002 the Company acquired all of the issued and
outstanding shares of Sharps Elimination Technologies Inc. ("SETI") in exchange
for 15,800,000 shares of the Company's common stock. The Agreement relating to
the acquisition of SETI provides that the 15,800,000 shares of common stock will
be returned to the Company and cancelled unless SETI sells at least 6,000
Needle-Ease devices by March 26, 2003. The 6,000 Needle-Ease devices must be
sold at an average price of U.S. $300 per unit and all sales must be verified by
receipt of cash no later than April 26, 2003.

         The August 2002 the Company and the former SETI shareholders agreed to
rescind the acquisition of SETI. See Note 1 of these financial statements for
further information.

         The Company does not have any bank lines of credit, or any other
traditional financing arrangements. The Company expects to obtain additional
capital through the private sale of the Company's common stock or from
borrowings from private lenders or financial institutions. There can be no
assurance that the Company will be successful in obtaining any additional
capital needed for its operations.


RESULTS OF OPERATIONS
---------------------

Nine Months Ended September 30, 2002
------------------------------------

         In June 2001 the Company acquired all of the issued and outstanding
equity securities of GrowthExperts Group Inc., a corporation formed to provide

                                       10
<PAGE>

outsourced sales and customer relationship management services. The acquisition
of GrowthExperts was treated as a reverse acquisition whereby the Company was
acquired by GrowthExperts. The financial statements for the period prior to the
date of acquisition (June 2001) were those of GrowthExperts. On December 5,
2001, GrowthExperts filed bankruptcy under Canada's Bankruptcy and Insolvency
Act due to lack of working capital. As a result of the bankruptcy filing, the
operating results for the nine months ended September 30, 2001 are shown as
"Discontinued Operations".

         Furthermore, in August 2002, our Company entered into a separation
agreement to sell all of the issued and outstanding shares of our operating
subsidiary, Sharps Elimination Technologies Inc. (formerly SETI Corp.), in
consideration for all of the shares of our common stock beneficially owned by
certain officers and directors of our Company, which totals 15,800,000. These
shares will be returned to treasury and cancelled. Following the share exchange,
our Company will no longer have any revenue generating assets or operations.


                                 PART I - ITEM 3
                             CONTROLS AND PROCEDURES

We maintain a system of internal controls and procedures designed to provide
reasonable assurance as to the reliability of our published financial statements
and other disclosures included in this report. Within the 90-day period prior to
the date of this report, under the supervision and with the participation of the
Company's management, we evaluated the effectiveness of the design and operation
of our disclosure controls and procedures pursuant to Rule 13a-14 of the
Securities Exchange Act of 1934 (the "1934 Act"). Based upon that evaluation, we
concluded that our disclosure controls and procedures are effective in timely
alerting us to material information relating to the Company required to be
included in the Company's periodic filings under the 1934 Act.

There have been no significant changes in our internal controls or in other
factors, which could significantly affect internal controls subsequent to the
date that we carried out our evaluation.

                                     PART II
                                OTHER INFORMATION

ITEM 1.  LEGAL PROCEEDINGS - NONE

ITEM 2.  CHANGES IN SECURITIES - NONE

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES - NONE

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS - NONE

ITEM 5.  OTHER INFORMATION - NONE

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

         (a)   The following exhibits are included herein:

               99.1     Certification of Director.

               99.2     Certification of Director.

         (b)   Reports on Form 8-K - None

                                       11
<PAGE>

                                   SIGNATURES

         Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the registrant has duly caused this registration statement to be
signed on its behalf by the undersigned, thereunto duly authorized.

                                            ARMAGH GROUP, INC

Date: November 12, 2002                     By: /s/ Darren Breitkreuz
                                                --------------------------------
                                                Darren Breitkreuz, Director

Date: November 12, 2002                     By: /s/ Adrian Towning
                                                --------------------------------
                                                Adrian Towning, Director

                                       12
<PAGE>

The following pages include the Signatures page for this Form 10-QSB,
Certifications of our CEO and CFO, and (at Exhibits 99.1 and 99.2 of this
report) a further Certification by our CEO and CFO.

The form of Certification immediately following the Signatures page is required
by Rule 15d-14 under the Securities Exchange Act of 1934 in accord with Section
302 of the Sarbanes-Oxley Act of 2002 (the "Section 302 Certification"). The
Section 302 Certification includes references to an evaluation of the
effectiveness of the design and operation of the Company's "disclosure controls
and procedures" and its "internal controls and procedures for financial
reporting". Item 3 of Part I of this quarterly report presents the conclusions
of the CEO and CFO about the effectiveness of such controls based on and as of
the date of such evaluation (relating to Item 4 of the Section 302
Certification), and contains additional information concerning disclosures to
our audit committee and independent auditors with regard to deficiencies in
internal controls and fraud (Item 5 of the Section 302 Certification) and
related matters (Item 6 of the Section 302 Certification).

The second form of Certification (set forth at Exhibit 99.1 and 99.2) is
required by section 1350 of chapter 63 of title 18 of the United States Code.


SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

ARMAGH GROUP INC.



        DATED: November 12, 2002            By: /s/  Darren Breitkreuz
                                                -----------------------
                                                     Darren Breitkreuz
                                                     Director

        DATED: November 12, 2002            By: /s/  Adrian Towning
                                               -----------------------
                                                     Adrian Towning
                                                     Director

                                       13
<PAGE>

                                  CERTIFICATION


I, Darren Breitkreuz, certify that:

1.       I have reviewed this quarterly report on Form 10-QSB of Armagh Group
         Inc.;

2.       Based on my knowledge, this quarterly report does not contain any
         untrue statement of material fact or omit to state a material fact
         necessary to make the statements made, in light of the circumstances
         under which such statements were made, not misleading with respect to
         the period covered by this quarterly report;

3.       Based on my knowledge, the financial statements, and other financial
         information included in this quarterly report, fairly present in all
         material respects the financial condition, results of operations and
         cash flows of the registrant as of, and for, the periods presented in
         this quarterly report;

4.       The registrant's certifying officers are responsible for establishing
         and maintaining disclosure controls and procedures (as defined in
         Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:

         a)       designed such disclosure controls and procedures to ensure
                  that material information relating to the registrant,
                  including its consolidated subsidiaries, is made known to us
                  by others within those entities, particularly during the
                  period in which this annual report is being prepared;

         b)       evaluated the effectiveness of the registrant's disclosure
                  controls and procedures as of a date within 90 days prior to
                  the filing date of this quarterly report (the "Evaluation
                  Date"); and

         c)       presented in this quarterly report our conclusions about the
                  effectiveness of the disclosure controls and procedures based
                  on our evaluation as of the Evaluation Date;

5.       The registrant's certifying officers have disclosed, based on our most
         recent evaluation, to the registrant's auditors and the audit committee
         of registrant's board of directors:

         a)       all significant deficiencies in the design or operation of
                  internal controls which could adversely affect the
                  registrant's ability to record, process, summarize and report
                  financial data and have identified for the registrant's
                  auditors any material weaknesses in internal controls; and

         b)       any fraud, whether or not material, that involves management
                  or other employees who have a significant role in the
                  registrant's internal controls; and

6.       The registrant's certifying officers have indicated in this quarterly
         report whether or not there were significant changes in internal
         controls or in other factors that could significantly affect internal
         controls subsequent to the date of our most recent evaluation,
         including any corrective actions with regard to significant
         deficiencies and material weaknesses.


Date: November 12, 2002


                                                /s/ Darren Breitkreuz
                                                ---------------------
                                                    Darren Breitkreuz
                                                    Director

                                       14
<PAGE>

                                  CERTIFICATION


I, Adrian Towning, certify that:

1.       I have reviewed this quarterly report on Form 10-QSB of Armagh Group
         Inc.;

2.       Based on my knowledge, this quarterly report does not contain any
         untrue statement of material fact or omit to state a material fact
         necessary to make the statements made, in light of the circumstances
         under which such statements were made, not misleading with respect to
         the period covered by this quarterly report;

3.       Based on my knowledge, the financial statements, and other financial
         information included in this quarterly report, fairly present in all
         material respects the financial condition, results of operations and
         cash flows of the registrant as of, and for, the periods presented in
         this quarterly report;

4.       The registrant's certifying officers are responsible for establishing
         and maintaining disclosure controls and procedures (as defined in
         Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:

         a)       designed such disclosure controls and procedures to ensure
                  that material information relating to the registrant,
                  including its consolidated subsidiaries, is made known to us
                  by others within those entities, particularly during the
                  period in which this annual report is being prepared;

         b)       evaluated the effectiveness of the registrant's disclosure
                  controls and procedures as of a date within 90 days prior to
                  the filing date of this quarterly report (the "Evaluation
                  Date"); and

         c)       presented in this quarterly report our conclusions about the
                  effectiveness of the disclosure controls and procedures based
                  on our evaluation as of the Evaluation Date;

5.       The registrant's certifying officers have disclosed, based on our most
         recent evaluation, to the registrant's auditors and the audit committee
         of registrant's board of directors:

         a)       all significant deficiencies in the design or operation of
                  internal controls which could adversely affect the
                  registrant's ability to record, process, summarize and report
                  financial data and have identified for the registrant's
                  auditors any material weaknesses in internal controls; and

         b)       any fraud, whether or not material, that involves management
                  or other employees who have a significant role in the
                  registrant's internal controls; and

6.       The registrant's certifying officers have indicated in this quarterly
         report whether or not there were significant changes in internal
         controls or in other factors that could significantly affect internal
         controls subsequent to the date of our most recent evaluation,
         including any corrective actions with regard to significant
         deficiencies and material weaknesses.


Date: November 12, 2002


                                                /s/ Adrian Towning
                                                -----------------------
                                                    Adrian Towning
                                                    Director

                                       15